Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)

Jonathan Silverberg; Lawrence Eichenfield; Andrew Blauvelt; Alan D. Irvine; Richard Langley; Emma Guttman; Richard Warren; Lars French; Claus Bang Pedersen; Anna Carlsson; Morten Lind Jensen; Morten O. A. Sommer; Kim Kjoller; Eric Simpson

doi:10.1093/bjd/ljae266.067

Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)

Jonathan Silverberg, Lawrence Eichenfield, Andrew Blauvelt, Alan D. Irvine, Richard Langley, Emma Guttman, Richard Warren, Lars French, Claus Bang Pedersen, Anna Carlsson, Morten Lind Jensen, Morten O. A. Sommer, Kim Kjoller, Eric Simpson

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	British Journal of Dermatology
Volume	191
Pages (from-to)	68-69
ISSN	0007-0963
DOIs	https://doi.org/10.1093/bjd/ljae266.067
Publication status	Published - 2024

Access to Document

10.1093/bjd/ljae266.067

OpenUrl availability

Full text

Cite this

Silverberg, J., Eichenfield, L., Blauvelt, A., Irvine, A. D., Langley, R., Guttman, E., Warren, R., French, L., Pedersen, C. B., Carlsson, A., Jensen, M. L., Sommer, M. O. A., Kjoller, K., & Simpson, E. (2024). Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS). British Journal of Dermatology, 191, 68-69. https://doi.org/10.1093/bjd/ljae266.067

@article{17ddc86bf35b428e942ddb1065e4a956,

title = "Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)",

author = "Jonathan Silverberg and Lawrence Eichenfield and Andrew Blauvelt and Irvine, {Alan D.} and Richard Langley and Emma Guttman and Richard Warren and Lars French and Pedersen, {Claus Bang} and Anna Carlsson and Jensen, {Morten Lind} and Sommer, {Morten O. A.} and Kim Kjoller and Eric Simpson",

year = "2024",

doi = "10.1093/bjd/ljae266.067",

language = "English",

volume = "191",

pages = "68--69",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

}

Silverberg, J, Eichenfield, L, Blauvelt, A, Irvine, AD, Langley, R, Guttman, E, Warren, R, French, L, Pedersen, CB, Carlsson, A, Jensen, ML, Sommer, MOA, Kjoller, K & Simpson, E 2024, 'Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)', British Journal of Dermatology, vol. 191, pp. 68-69. https://doi.org/10.1093/bjd/ljae266.067

Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS). / Silverberg, Jonathan; Eichenfield, Lawrence; Blauvelt, Andrew et al.
In: British Journal of Dermatology, Vol. 191, 2024, p. 68-69.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)

AU - Silverberg, Jonathan

AU - Eichenfield, Lawrence

AU - Blauvelt, Andrew

AU - Irvine, Alan D.

AU - Langley, Richard

AU - Guttman, Emma

AU - Warren, Richard

AU - French, Lars

AU - Pedersen, Claus Bang

AU - Carlsson, Anna

AU - Jensen, Morten Lind

AU - Sommer, Morten O. A.

AU - Kjoller, Kim

AU - Simpson, Eric

PY - 2024

Y1 - 2024

U2 - 10.1093/bjd/ljae266.067

DO - 10.1093/bjd/ljae266.067

M3 - Conference abstract in journal

SN - 0007-0963

VL - 191

SP - 68

EP - 69

JO - British Journal of Dermatology

JF - British Journal of Dermatology

ER -